HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 30 August 2011

New NICE topic for HEDS

ScHARR-TAG have had a new topic confirmed.  It is:

Adalimumab, etanercept, infliximab, certolizumab pegol and golimumab for the treatment of rheumatoid arthritis.  Review of TA130, TA186 and TA225.

Even with our considerable expertise in this area, this is going to be a massive piece of work – there are big issues around network meta-analysis, model structure, mapping and extrapolation.  And five manufacturer submissions!